SELLAS Life Sciences SLS
NASDAQ SLS
$12.31 +0.80 (+6.99%)
As of: Sep 30, 2026 · 3:14 PM EDT

SELLAS Life Sciences (SLS) EV to CFO (2017)

Updated

SELLAS Life Sciences' EV to CFO was 26.94 in Q3 2017, down 74.5% from the prior quarter.

Analysis

SELLAS Life Sciences (SLS) EV to CFO (2017) Analysis & Trends

On a trailing twelve-month basis, SELLAS Life Sciences' EV to CFO was 24.27 through Sep 30, 2017.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 SELLAS Life Sciences 2.32 Bn 2.32 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 26.94
Jun 30, 2017 105.46
API Access

SELLAS Life Sciences EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=SLS&period=max&api_key=YOUR_API_KEY